Imugene Limited (IMU) is an Australian immuno-oncology focused Biopharmaceutical Company developing HER2 + ve gastric and breast cancer vaccines. The Group’s lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu.
Imugene Limited operators in Health Care sector and under industry of Biotechnology. The company website is: http://www.imugene.com.
You can also check out dividend history for similar stocks in the same sector as follows:
IMU Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found